Overnight deprivation from smoking disrupts amygdala responses to fear

Human Brain Mapping

Volumn 33, Issue 6, 2012, Pages 1407-1416

  Onur, Oezguer A ^a,b   Patin, Alexandra ^a   Mihov, Yoan ^a   Buecher, Boris ^a   Stoffel Wagner, Birgit ^a   Schlaepfer, Thomas E ^a,c   Walter, Henrik ^a,d   Maier, Wolfgang ^a   Hurlemann, René ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Addiction; Amygdala; Dependence; Faces; Fear; FMRI; Nicotine; Smoking

Indexed keywords

CARBON MONOXIDE;

ADULT; AMYGDALOID NUCLEUS; ARTICLE; BASOLATERAL AMYGDALA; BRAIN FUNCTION; BRAIN MAPPING; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; EXHALATION; FEAR; FEMALE; HIGH RISK BEHAVIOR; HUMAN; MALE; NEUROBIOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERNIGHT DEPRIVATION; PRIORITY JOURNAL; SMOKING CESSATION; TOBACCO DEPENDENCE;

ADULT; AMYGDALA; BRAIN MAPPING; FEAR; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEUROPSYCHOLOGICAL TESTS; PERSONALITY; SMOKING; SMOKING CESSATION; SUBSTANCE WITHDRAWAL SYNDROME; VISUAL PERCEPTION;

EID: 84860836490     PISSN: 10659471     EISSN: 10970193     Source Type: Journal    
DOI: 10.1002/hbm.21293     Document Type: Article

References (64)

1. Adolphs R (2010): What does the amygdala contribute to social cognition? Ann N Y Acad Sci 1191: 42-61.
2. Adolphs R, Tranel D, Damasio H, Damasio A (1994): Impaired recognition of emotion in facial expressions following bilateral damage to the human amygdala. Nature 372: 669-672.
3. Adolphs R, Tranel D, Damasio A (1998): The human amygdala in social judgment. Nature 393: 470-474.
4. Adolphs R, Gosselin F, Buchanan TW, Tranel D, Schyns P, Damasio AR (2005): A mechanism of impaired fear recognition after amygdala damage. Nature 433: 68-72.
5. Amunts K, Kedo O, Kindler M, Pieperhoff P, Mohlberg H, Shah NJ, Habel U, Scheider F, Zilles K (2005): Cytoarchitectonic mapping of the human amygdala, hippocampal region and entorhinal cortex: Intersubject variability and probability maps. Anat Emryol 210: 343-352.
6. Ashburner J, Friston KJ (2003): Rigid body registration. In: Frackowiak RS, Friston KJ, Frith CD, Dolan RJ, Price CJ, Ashburner J, Penny WD, Zeki S, editors. Human Brain Function, 2nd ed. London, UK: Academic Press. pp 635-655.
7. Batra A (2000): Tobacco use and smoking cessation in the psychiatric patient. Fortschr Neurol Psychiatr 68: 80-92.
8. Beck AT, Steer RA, Ball R, Rainieri W (1996): Comparison of beck depression inventories -IA and -II in psychiatric outpatients. J Pers Assess 67: 588-597.
9. Benowitz NL (2010): Nicotine addiction. N Engl J Med 362: 2295-2303.
10. Bleich S, Havemann-Reinecke U, Kornhuber J (2002): Der Fagerström-Test für Nikotinabhängigkeit (FTNA). Göttingen: Hogrefe.
11. Borkenau P, Ostendorf F (1993): NEO-Fünf-Faktoren-Inventar (NEO-FFI) nach Costa und McCrae. Göttingen: Hogrefe.
12. Brody AL, Mandelkern MA, London ED, Olmstead RE, Farahi J, Scheibal D, Jou J, Allen V, Tiongson E, Chefer SI, Koren AO, Mukhin AG (2006): Cigarette smoking saturates brain α4 β2 nicotinic acetylcholine receptors. Arch Gen Psychiatry 63: 907-915.
13. Changeux JP (2010): Nicotine addiction and nicotinic receptors: Lessons from genetically modified mice. Nat Rev Neurosci 11: 389-401.
14. Cloninger CR (1987): A systematic method for clinical description and classification of personality variants: A proposal. Arch Gen Psychiatry 44: 573-588.
15. Collins DL, Neelin P, Peters TM, Evans AC (1994): Automatic 3D intersubject registration of MR volumetric data in standardized Talairach space. J Comput Assist Tomogr 18: 192-205.
16. Costa PT Jr, McCrae RR (1985): The NEO Personality Inventory Manual. Odessa, FL: Psychological Assessment Resources.
17. Dome P, Lazary J, Kalapos MP, Rihmer Z (2010): Smoking, nicotine and neuropsychiatric disorders. Neurosci Biobehav Rev 34: 295-342.
18. Eickhoff SB, Stephan KE, Mohlberg H, Grefkes C, Fink GR, Amunts K, Zilles K (2005): A new SPM toolbox for combining probabilistic cytoarchitectonic maps and functional imaging data. Neuroimage 25: 1325-1335.
19. Evans AC, Marrett S, Neelin P, Collins L, Worsley K, Dai W, Milot S, Meyer E, Bub D (1992): Anatomical mapping of functional activation in stereotactic coordinate space. Neuroimage 1: 43-53.
20. Evans AC, Kamber M, Collins DL, MacDonald D (1994): An MRI based probabilistic atlas of neuroanatomy. In: Shorvon S, Fish D, Andermann F, Bydder GM, editors. Magnetic Resonance Scanning and Epilepsy. New York: Plenum; 263-274.
21. Friston KJ, Holmes A, Worsley KJ, Poline JB, Frith CD, Frackowiak RSJ (1995): Statistical parametric maps in functional imaging: A general linear approach. Hum Brain Mapp 2: 189-210.
22. Funayama ES, Grillon C, Davis M, Phelps EA (2001): A double dissociation in the affective modulation of startle in humans: Effects of unilateral temporal lobectomy. J Cogn Neurosci 13: 721-729.
23. Gallinat J, Meisenzahl E, Jacobsen LK, Kalus P, Bierbrauer J, Kienast T, Witthaus H, Leopold K, Seifert F, Schubert F, Staedtgen M (2006): Smoking and structural brain deficits: A volumetric MR investigation. Eur J Neurosci 24: 1744-1750.
24. Goossens L, Kukolja J, Fink GR, Maier W, Griez EJ, Schruers K, Hurlemann R (2009): Selective processing of social stimuli in the superficial amygdala. Hum Brain Mapp 30: 3332-3338.
25. Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO (1991): The Fagerström Test for Nicotine Dependence: A revision of the Fagerström Tolerance Questionnaire. Br J Addict 86: 1119-1127.
26. Helmstaedter C, Lendt M, Lux S (2001): VLMT-Verbaler Lern und Merkfähigkeitstest. Göttingen: Beltz.
27. Holmes CJ, Hoge R, Collins L, Woods R, Toga AW, Evans AC (1998): Enhancement of MR images using registration for signal averaging. J Comput Assist Tomogr 22: 324-333.
28. Hong LE, Gu H, Yang Y, Ross TJ, Salmeron BJ, Buchholz B, Thaker GK, Stein EA (2009): Association of nicotine addiction and nicotine's actions with separate cingulate cortex functional circuits. Arch Gen Psychiatry 66: 431-441.
29. Hughes JR, Hatsukami D (1986): Signs and symptoms of tobacco withdrawal. Arch Gen Psychiatry 43: 289-294.
30. Hurlemann R, Rehme AK, Diessel M, Kukolja J, Maier W, Walter H, Cohen MX (2008): Segregating intra-amygdalar responses to dynamic facial emotion with cytoarchitectonic maximum probability maps. J Neurosci Methods 172: 13-20.
31. Hurlemann R, Schlaepfer TE, Matusch A, Reich H, Shah NJ, Zilles K, Maier W, Bauer A (2009): Reduced 5-HT(2A) receptor signaling following selective bilateral amygdala damage. Soc Cogn Affect Neurosci 4: 79-84.
32. Hurlemann R, Walter H, Rehme AK, Kukolja J, Santoro SC, Schmidt C, Schnell K, Musshoff F, Keysers C, Maier W, Kendrick KM, Onur OA (2010): Human amygdala reactivity is diminished by the beta-noradrenergic antagonist propranolol. Psychol Med 27: 1-10.
33. Iwahashi K, Aoki J (2009): A review of smoking behavior and smokers evidence (chemical modification, inducing nicotine metabolism, and individual variations by genotype: Dopaminergic function and personality traits). Drug Chem Toxicol 32: 301-306.
34. Jarvik ME, Madsen DC, Olmstead RE, Iwamoto-Schaap PN, Elins JL, Benowitz NL (2000): Nicotine blood levels and subjective craving for cigarettes. Pharmacol Biochem Behav 66: 553-558.
35. Killen JD, Fortmann SP (1997): Craving is associated with smoking relapse: Findings from three prospective studies. Exp Clin Psychopharmacol 5: 137-142.
36. Koob GF (2009): Brain stress systems in the amygdala and addiction. Brain Res 1293: 61-75.
37. LaBar KS, Gatenby JC, Gore JC, LeDoux JE, Phelps EA (1998): Human amygdala activation during conditioned fear acquisition and extinction: A mixed-trial fMRI study. Neuron 20: 937-945.
38. LeDoux J (2007): The amygdala. Curr Biol 17: R868-R874.
39. Lundqvist D, Flykt A, Ohman A (1998): The Karolinska Directed Emotional Faces-KDEF [CD-ROM]. Stockholm, Sweden: Department of Clinical Neuroscience, Psychology section, Karolinska Institutet.
40. Malecki R, Zdrojowy K, Adamiec R (2009): Thromboangiitis obliterans in the 21st century-A new face of disease. Atherosclerosis 206: 328-334.
41. McNair DM, Lorr M, Doppleman LF (1971): EITS Manual for Profile of Mood States. San Diego, CA: Educational and Industrial Testing Service.
42. Mueller V, Mucha RF, Ackermann K, Pauli P (2001): The assessment of craving in smokers with a German version of the "Questionnaire on Smoking Urges" (QSU-G). Zeitschrift fur Klinische Psychologie 30: 164-171.
43. Oldfield RC (1971): The assessment and analysis of handedness: The Edinburgh inventory. Neuropsychologia 9: 97-113.
44. Onur OA, Walter H, Schlaepfer TE, Rehme AK, Schmidt C, Keysers C, Maier W, Hurlemann R (2009): Noradrenergic enhancement of amygdala responses to fear. Soc Cogn Affect Neurosci 4: 119-126.
45. Phan KL, Wager T, Taylor SF, Liberzon I (2002): Functional neuroanatomy of emotion: A meta-analysis of emotion activation studies in PET and fMRI. Neuroimage 16: 331-348.
46. Quirk GJ, Gehlert DR (2003): Inhibition of the amygdala: Key to pathological states? Ann N Y Acad Sci 985: 263-272.
47. Reinders AA, den Boer JA, Buchel C (2005): The robustness of perception. Eur J Neurosci 22: 524-530.
48. Rey LB (1941): L'examen psychologique dans les cas d'encephalopathie traumatique. Arch Psychol 28: 286-340.
49. Robinson TA, Berridge KC (2001): Incentive-sensitization and addiction. Addiction 96: 103-114.
50. Sabol SZ, Nelson ML, Fisher C, Gunzerath L, Brody CL, Hu S, Sirota LA, Marcus SE, Greenberg BD, Lucas FR IV, Benjamin J, Murphy DL, Hamer DH (1999): A genetic association for cigarette smoking behavior. Health Psychol 18: 7-13.
51. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC (1998): The Mini-International Neuropsychiatric Interview (M.I.N.I.) the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59 (Suppl 20): 22-33.
52. Shiffman S, West R, Gilbert D; SRNT Work Group on the Assessment of Craving and Withdrawal in Clinical Trials (1997): Recommendation for the assessment of tobacco craving and withdrawal in smoking cessation trials. Nicotine Tob Res 6: 599-614.
53. Shiffman S, Paty JA, Gwaltney CJ, Dang Q (2004): Immediate antecedents of cigarette smoking: An analysis of unrestricted smoking patterns. J Abnorm Psychol 113: 166-171.
54. Stead LF, Perera R, Bullen C, Mant D, Lancaster T (2008): Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 1: CD000146.
55. Stoecker T, Schneider F, Klein M, Habel U, Kellermann T, Zilles K, Shah NJ (2005): Automated quality assurance routines for fMRI data applied to a multicenter study. Hum Brain Mapp 25: 237-246.
56. Vuilleumier P, Armony JL, Driver J, Dolan RJ (2001): Effects of attention and emotion on face processing in the human brain: An event-related fMRI study. Neuron 30: 829-841.
57. Wang Z, Faith M, Patterson F, Tang K, Kerrin K, Wileyto EP, Detre JA, Lerman C (2007): Neural substrates of abstinence-induced cigarette cravings in chronic smokers. J Neurosci 27: 14035-14040.
58. Wechsler D (1997): Wechsler Adult Intelligence Scale. Administration and Scoring Manual, 3rd ed. San Antonio, TX: Psychological Corporation.
59. Weyers P, Krebs H, Janke W (1995): Reliability and construct validity of the German version of Cloninger's Tridimensional Personality Questionnaire. Pers Individ Dif 19: 853-861.
60. Whalen PJ, Shin LM, McInerney SC, Fischer H, Wright CI, Rauch SL (2001): A functional MRI study of human amygdala responses to facial expressions of fear versus anger. Emotion 1: 70-83.
61. Wojciulik E, Kanwisher N, Driver J (1998): Covert visual attention modulates face-specific activity in the human fusiform gyrus: fMRI study. J Neurophysiol 79: 1574-1578.
62. Young AW, Perrett DI, Calder AJ, Sprengelmeyer R, Ekman P (2002): Facial Expressions of Emotion: Stimuli and Tests (FEEST). Bury St. Edmunds: Thames Valley Test Company.
63. Yovel G, Kanwisher N (2004): Face perception: Domain specific, not process specific. Neuron 44: 889-898.
64. Zarrindast MR, Solati J, Oryan S, Parivar K (2008): Effect of intra-amygdala injection of nicotine and GABA receptor agents on anxiety-like behaviour in rats. Pharmacology 82: 276-284.